The Sustainable Healthcare Podcast

Care Pathway Consulting Aps

Learn the dos and don'ts of green innovation from experienced industry leaders. Your hosts are Frederik Dam van Deurs and Joachim Almdal.

  1. 098 - Tackling Pharmaceutical Pollution: A Systems-Based Approach

    FEB 3

    098 - Tackling Pharmaceutical Pollution: A Systems-Based Approach

    Tackling Pharmaceutical Pollution: A Systems-Based Approach In this episode of the Sustainable Healthcare Podcast, host Frederik Dam van Deurs welcomes Kelly Thornber, a researcher and advocate for addressing pharmaceutical pollution. Kelly shares her journey from working in Bangladesh to identifying pharmaceutical pollution as a global issue, and discusses the systems-based approach needed to mitigate its risks to public and environmental health. Episode Summary Kelly Thornber discusses the complexity of pharmaceutical pollution and the need for a systems-based strategy to address it. She highlights the importance of understanding the entire lifecycle of pharmaceuticals, from manufacture to disposal, and the role of various stakeholders in creating a sustainable solution. Key Topics CoveredIntroduction to Kelly Thornber:Kelly discusses her background and how she became interested in pharmaceutical pollution while working in Bangladesh.Her journey into sustainability and how her department is driving change within the company. Understanding Pharmaceutical Pollution:The importance of addressing pharmaceutical pollution and its impact on public and environmental health.The complexity of the pharmaceutical system and the need for a systems-based approach to mitigate risks. The Role of the Pharma Pollution Hub:Kelly’s work with the Pharma Pollution Hub and their efforts to advocate for changes in the pharmaceutical industry.The need for independent facilitation and oversight to drive meaningful change. Identifying Intervention Points:The 37 intervention points identified in Kelly’s paper and the importance of starting with actionable steps.The role of stakeholders in implementing these interventions and the need for collaboration.Notable Quotes"Pharmaceuticals are designed to be biologically active, and that means they can have physiological effects in non-target species." - Kelly Thornber"We need to take a systems approach to address the complex issue of pharmaceutical pollution." - Kelly ThornberResources MentionedPharma Pollution Hub: Pharma Pollution Hub WebsitePharmaceutical Pollution Paper: Read the PaperCall to ActionShare your thoughts: What role should the pharmaceutical industry play in addressing pollution? Connect with Frederik on LinkedIn to share your insights.Subscribe and Share: Help spread the word about sustainable healthcare by subscribing to the podcast and sharing this episode with your network.Host: Frederik Dam van Deurs Guest: Kelly Thornber, Researcher and Advocate for Pharmaceutical Pollution

    39 min
  2. 097 - Visualizing Circular Healthcare: A Taxonomy for Sustainable Medical Device Flows

    JAN 29

    097 - Visualizing Circular Healthcare: A Taxonomy for Sustainable Medical Device Flows

    Guest: Tamara, PhD Candidate at TU Delft, Department of Sustainable Design Engineering Episode Summary In this episode of the Sustainable Healthcare Podcast, host Frederik Dam van Deurs welcomes Tamara, a researcher and entrepreneur specializing in circular economy principles for healthcare. Tamara shares her groundbreaking work on the Visual Taxonomy of Circular Healthcare Flows (CHF), a comprehensive map designed to guide sustainable decision-making for medical devices from design to end-of-life. Key Topics Covered The Visual Taxonomy of Circular Healthcare FlowsTamara introduces her visual taxonomy, which maps out circular economy strategies for medical devices. The taxonomy is designed to clarify the often-confusing terminology (e.g., "reuse" vs. "recycling") and provide actionable pathways for sustainability.Visual Reference: Visual Taxonomy of Circular Healthcare Flows (CHF) Misconceptions in Circular Economy TerminologyTamara highlights common misunderstandings, such as the difference between "reuse" and "recycling," and the healthcare-specific term "reprocessing." She emphasizes the importance of clarity in communication to avoid unintended environmental impacts. Real-World Example: Laparoscopic StaplerUsing a laparoscopic stapler as a case study, Tamara walks through the taxonomy’s steps: Refuse (questioning the need for the device), Rethink (designing multifunctional devices), Reduce (minimizing material use), and Reuse/Recycle (extending product life through maintenance, repair, or reprocessing). Barriers to Circularity in HealthcarePerceived vs. Actual Safety: The tendency to prioritize perceived safety over evidence-based sustainability, leading to overuse of single-use devices and excessive waste.Logistical Challenges: The complexity of sorting and collecting devices, especially in hospitals with limited space and resources.Regulatory Hurdles: Differences in regulations between the EU and the US, such as the reprocessing of single-use devices. Innovations and Hope for the FutureTamara shares her work on a patient-friendly alternative to the traditional vaginal speculum, designed to reduce pain and improve accessibility. She also discusses her optimism about collaborations among medical device manufacturers to drive systemic change.Notable Quotes "The number one barrier is the difference between actual safety and perceived safety. People want to do well in healthcare, but this can lead to unintended environmental consequences.""We need to ask: Do we really need this device? Can we refuse, rethink, or reduce before we even start producing?""Sterilization is not always necessary - sometimes high-level disinfection is enough, and that can significantly reduce environmental impact."Resources Mentioned Visual Taxonomy of Circular Healthcare Flows (CHF): View the VisualCall to Action Share your thoughts: What circular economy strategies have you seen in healthcare? Connect with Frederik on LinkedIn to share your insights. Subscribe and Share: Help spread the word about sustainable healthcare by subscribing to the podcast and sharing this episode with your network.Host: Frederik Dam van Deurs Guest: Tamara, PhD Candidate, TU Delft

    38 min
  3. 12/08/2025

    095 - Face Blindness aka Developmental Prosopagnosia with Erling Nørkær

    Developmental prosopagnosia – also known as face blindness – affects an estimated 1–3% of the population, yet most people have never heard of it. In this special episode of the Sustainable Healthcare Podcast, Frederik steps into the role of patient and speaks with psychologist and researcher Erling Nørkær about his own recent condition discovery and what it means to live in a world where faces don’t reliably “stick.” Together, Frederik and Erling unpack: What developmental prosopagnosia is – and how it differs from simply being “bad with names” How face recognition normally works in the brain, and what seems to go wrong in prosopagnosia The social and emotional consequences: fear of seeming rude, anxiety in crowds, and why modern life makes the condition harder to live with Practical coping strategies and how people learn to rely on clothing, context, voice, and other cues instead of faces Why prosopagnosia is not yet a formal diagnosis, and what that means for patients Current research efforts, including studies of infants of parents with prosopagnosia, and what this might reveal about early development and future interventionsIt’s a deeply personal conversation about neurodivergence, identity, and how better language and awareness can make everyday life less stressful for people with face blindness – in schools, workplaces, and healthcare. About our guest Erling Nørkær is a psychologist, PhD, and researcher at the Department of Psychology, University of Copenhagen, specializing in developmental prosopagnosia – the reduced or absent ability to recognize faces. LinkedIn: https://www.linkedin.com/in/erling-n%C3%B8rk%C3%A6r-0558a11b8/ Copenhagen Neuropsychology Lab (CopNL): https://psychology.ku.dk/research/research_groups/copnl/ Research profile: https://researchprofiles.ku.dk/en/persons/erling-n%C3%B8rk%C3%A6r/

    36 min
  4. 11/27/2025

    093 - Exercise in health Anders Nedergaard

    The Power of Movement: Why Exercise is Essential for Health In this episode of the Sustainable Healthcare Podcast, host Joachim Almdal welcomes Anders Nedergaard, an expert in muscle biology and health coaching. Anders shares his insights on the importance of physical activity, the impact of modern lifestyles on health, and how exercise can be integrated into healthcare systems to promote sustainability. Episode Summary Anders Nedergaard, with a PhD in muscle biology, discusses the critical role of physical activity in maintaining health and preventing disease. He highlights the benefits of exercise, from improving cardiometabolic health to reducing inflammation, and explores the societal changes that have led to decreased physical activity levels. Key Topics CoveredThe Benefits of Exercise:Anders explains how physical activity normalizes and stabilizes physiological homeostasis, including blood sugar regulation, lipid levels, blood pressure, and mood.The importance of maintaining a high oxygen uptake to counter the negative effects of being overweight or obese.Modern Lifestyles and Health:The impact of inactivity and caloric surplus on health outcomes.The paradox of occupational vs. recreational physical activity and their different effects on health.Exercise Dosage and Health Outcomes:The relationship between various doses of exercise and health outcomes, including mortality and morbidity.The concept of "involuntary physical activity abstinence" and how it affects public health.Integrating Exercise into Healthcare:The potential for exercise to reduce healthcare emissions by preventing intensive care needs.The challenges and opportunities of incorporating exercise into healthcare systems.Notable Quotes"Physical activity in general normalizes and stabilizes all kinds of physiological homeostasis." - Anders Nedergaard"The real big difference is when you go from zero to something." - Anders Nedergaard

    23 min
  5. 11/05/2025

    092 Planetary Boundaries & Health with Mia Heide from WELA

    Planetary boundaries, wellbeing & healthcare with Mia Heide (WELA) What does it actually mean for human health that we’ve now exceeded 7 out of 9 planetary boundaries – up from 6 out of 9 in 2023 – and how should healthcare systems respond?  In this episode, we're joined by Mia Heide, engineer and researcher at WELA – Wellbeing Economy Lab, to unpack the latest science and what it implies for policy, practice, and care pathways. Sustainable Healthcare Podcast … We talk about:What the planetary boundaries framework is – and why it’s about hard limits, not “nice-to-have” goalsThe new 2025 assessment showing we’ve transgressed 7/9 boundaries, and what changed since 2023 How to downscale planetary boundaries to a country level (e.g. Denmark) using different sharing principles – equal per capita, capacity to reduce, historical responsibility, and “grandfathering”  Why some principles give wealthy countries like Denmark a negative carbon budget, and why “equal” is not the same as “fair” The concept of decent living standards – what’s the minimum energy and material footprint needed to secure basic human needs globally?  Health impacts of specific boundaries once we overshoot them, including:Climate change: extreme weather, heat stress, displacement and food securityFreshwater change: water scarcity, sanitation breakdown, conflict riskNovel entities (PFAS, microplastics, synthetic chemicals): cancer risk, hormone disruption, fertility impacts – and why this is hugely under-discussed in public health  The uncomfortable paradox: we need to meet basic needs and stay within limits – and every tonne of CO₂ still counts Why healthcare decarbonisation must be seen in a two-way relationship:Healthcare activities impact planetary boundariesOvershooting those boundaries, in turn, undermines population health and health system resilience Where Mia still finds motivation and drive in 2025 – and why “a different world is possible” is not just a sloganAbout our guest – Mia Heide & WELA Mia Heide is an engineer and researcher at WELA – Wellbeing Economy Lab, a Danish, independent think tank working for a wellbeing economy where societal progress is measured by the ability to create good lives for all within planetary boundaries – now and for future generations. Resources & links mentionedMia’s working paper (in Danish) “Trivsel inden for de planetære grænser” – WELA working paper on planetary boundaries, wellbeing and health 👉 WELA publications page: https://www.wellbeingeconomylab.com/udgivelserDecent living standards & minimum energy Millward-Hopkins et al. (2020): “Providing decent living with minimum energy: A global scenario” 👉 https://www.sciencedirect.com/science/article/pii/S0959378020307512Planetary boundaries & latest assessmentsRichardson et al. (2023) – updated assessment of the planetary boundaries (Stockholm Resilience Centre)Planetary Health Check 2025 – Executive Summary (global status update) 👉 https://www.planetaryhealthcheck.org/wp-content/uploads/PlanetaryHealthCheck2025_ExecutiveSummary.pdfIf you enjoyed this episode, please share it with a colleague, rate the show, or suggest future guests – it really helps us bring more voices like Mia’s into the sustainable healthcare conversation.

    39 min
  6. 10/27/2025

    091 SHC - the Sustainable Healthcare Coalition - Fiona Adshead, Keith Moore and Nathalie Preiswerk

    Show Notes — Sustainable Healthcare Coalition (SHC): From Care Pathways to Greener Clinical Trials Guests:Fiona — Chair, Sustainable Healthcare Coalition (SHC)Keith Moore — Programme Coordinator, SHCNatalie — Community of Practice Moderator, SHCHost: Frederik Dam van Deurs (Green Innovation Group & Care Pathway Consulting) Episode in a nutshell We sit down with the Sustainable Healthcare Coalition (SHC) to unpack what it really takes to decarbonize healthcare—both at the level of everyday care pathways and the specialized world of clinical trials. We cover SHC’s origin story with the NHS, why scope 3 (supply chain) matters, how SHC evolved into a not-for-profit platform connecting public and private actors, and the tools and frameworks helping systems act now. Natalie also previews the first in-person conference of the Sustainable Clinical Trials – Community of Practice in London on 4 November 2025—a highly interactive day shaping the community’s 2026 agenda. What we coverSHC origin & mission: From a UK roundtable (2011) to a global, not-for-profit platform bridging health systems and industry on sustainability.Why scope 3 is the big lever: Pharma and med-tech footprints, and how collaborative forums beat procurement-only dialogues.Three universal priorities for greener care:Shift care closer to the patient,Use digital tools to empower patients and providers,Double down on prevention.Prevention in practice: Partnering with people, designing prevention into systems (e.g., vaccination, slowing CKD progression), and supporting self-management (e.g., smart inhalers).Care pathways vs. clinical trials: Why trials deserve their own framework (CROs, labs, regulators, logistics) even if they mirror care pathways.Where trial emissions often sit: Participant travel, site/monitor travel, labs, and investigational product logistics—plus the promise (and limits) of decentralization.Start here: Assess your own trial portfolio and therapeutic areas—hotspots and best levers vary with the carbon intensity of the product/API and trial design.Hope, pragmatism & momentum: System optimization saves costs and resources and cuts CO₂e—progress doesn’t have to feel like sacrifice.Key takeawaysSystems thinking wins: Cross-sector collaboration is essential; no single stakeholder can decarbonize healthcare alone.Measure to move: Practical calculators and worked examples help teams find hotspots and act fast.Prevention is premium care: The most sustainable pathway is the one where patients don’t get sick—but it requires genuine partnership with people.Memorable moments“The most sustainable patient journey is the one where the patient never gets sick.”“Clinical trials are like care pathways with extra moving parts—CROs, labs, ethics, regulators—so they need their own rulebook.”“Even if climate isn’t your prime driver, system optimization cuts waste and saves money—why wouldn’t you do it?”Links & resourcesSHC COP Conference (London, 4 Nov 2025): shcoalition.org/cop-conference/Sustainable Healthcare Coalition (main site): shcoalition.orgLinkedIn Group – Sustainable Clinical Trials: Community of Practice: linkedin.com/groups/13149469/

    33 min

About

Learn the dos and don'ts of green innovation from experienced industry leaders. Your hosts are Frederik Dam van Deurs and Joachim Almdal.